Addition of Spironolactone in Patients With Resistant Arterial Hypertension

PHASE4UnknownINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hypertension
Interventions
DRUG

spironolactone

25 mg of spironolactone once daily or placebo for 2 months

Trial Locations (1)

775 20

RECRUITING

Olomouc University Hospital and Palacký University School of Medicine, Olomouc

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Czech Society of Hypertension

OTHER

collaborator

Prostejov Hospital

UNKNOWN

collaborator

Brno University Hospital

OTHER

collaborator

Olomouc Military Hospital

UNKNOWN

collaborator

Gedeon Richter Ltd.

INDUSTRY

lead

Jan Vaclavík

OTHER